Empagliflozin (SGLT2i)

DRUG2 trials

Sponsors

Kaiser Permanente, Hotel Dieu de France Hospital

Conditions

CAD - Coronary Artery DiseaseCardiovascular DiseasesInflamationPCISGLT 2 InhibitorsType 2 Diabetes Mellitus

Phase 4

Effect of Empagliflozin on Inflammation

RecruitingNCT07292909

Hotel Dieu de France HospitalCAD - Coronary Artery Disease, Inflamation, PCI +1

Start: 2025-09-01End: 2027-09-30Target: 100Updated: 2025-12-18

Unknown Phase

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

CompletedNCT05073692

Kaiser PermanenteCardiovascular Diseases, Type 2 Diabetes Mellitus

Start: 2021-07-01End: 2025-03-12Updated: 2025-11-21